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I. INTRODUCTION
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia in clinical practice and causes significant morbidity and mortality.
1, 2 Although many risk factors for AF such as advanced age, hypertension, structural heart disease, and congestive heart failure have been identified, a subset of younger subjects develops AF in the absence of established risk factors. The mechanisms underlying AF are not fully understood, but growing evidence supports a heritable component underlying AF and genetic variation may play a role in its pathogenesis. 3 Familial cases among young patients with lone AF underscore a genetic basis for disease, 4 and research implicates pathogenic mutations and risk-conferring functional polymorphisms in AF development. 13 Meanwhile, one of the long-term risk factors for AF is prolonged PR interval on electrocardiography (ECG). 14 Increased P-wave duration has been reported to indicate abnormal phenotypic characteristics such as left or right atrial hypertrophy and or enlargement, which reflect delayed intra-or inter-atrial conduction. 15 Multiple researches have also shown the value of P-wave prolongation as a predictor for AF after cardiac interventions such as coronary artery bypass surgery. 16, 17 Genetic variants in 4q25 and 16q22 and PR intervals also have been reported to dispose individuals to AF. 18, 19 Recently, AF has been most effectively treated with radiofrequency catheter ablation (RFCA), a procedure that isolates and terminates the source of ectopic activity. 20 As the use of RFCA is increasing around the world, 21 analysis of pre-procedural characteristics that stratify the procedural efficacy and safety might be helpful, given the cost and potential complications of this procedure. 22 Interestingly, 4q25 SNP recently has been reported to predict the recurrence of AF after RFCA. 23 In this study, we hypothesized that phenotypes of AF patients including electroanatomical characteristics of left atrium (LA) and recurrence after RFCA were modulated by the common AF susceptibility alleles, rs2200733 and rs6843082 at 4q25, rs2106261 at ZFHX3, and rs13376333 at KCNN3.
II. MATERIALS AND METHODS
Study population
The study protocol was approved by the Institutional Review Board of the Yonsei University Health System and adhered to the Declaration of Helsinki. were identified under isoproterenol, they were all ablated.
Post-ablation follow-up
Patients were asked to visit an outpatient clinic at 1, 3, 6, and 12 months after RFCA and then every 6 months thereafter for follow-up. ECG was performed at each visit and anytime the patient reported palpitations. A Holter ECG (24-or 48-hour) and/or event recorder was performed on patient at every sixmonth follow-up and whenever the patient complained of symptoms for at least two years according to 2012 ACC/AHA/ESC expert consensus guideline for AF management. 26 We defined recurrence of AF as any episode of AF or atrial tachycardia of at least 30 seconds in duration. 27 If AF was found on ECG within the three-month of blanking period during follow-up, the patient was diagnosed with early recurrence of AF, and any AF recurrence thereafter was diagnosed as clinical recurrence 27 and antiarrhythmic medications were prescribed.
Off-line analyses of color-coded 3-D maps and CT images
Color-coded voltage maps were generated by recording bipolar electrograms and measuring peak-to-peak voltage during high right atrial pacing with a cycle length of 500 ms as previously described. 28 We analyzed color-coded voltage maps of both anterior-posterior (AP) and posterior-anterior (PA) views that had been converted to image files as previously reported. 29 PVs
were not included in the analysis. Digital measurements of color-coded voltage maps were performed by a single investigator, using a consistent USA.). To calculate local conduction velocity, the conduction distance was measured on the AP and PA views of the isochronal map, and the measured distance on the isochronal map were divided by the time difference as described before. 28 The 3D spiral CT images of LA were analyzed on an image processing workstation (Aquarius, Terarecon Inc., USA). Each LA image was divided into portions according to the embryological origin as follows: the venous LA (posterior LA including the antrum and posterior wall),
anterior LA (excluding the LA appendage and venous LA), and LA appendage.
The absolute and relative volumes of each portion were calculated and compared.
Electrocardiography
Standard 12 lead ECGs were recorded few hours to a day before catheter ablation procedure. Digitally stored ECGs were magnified at a high resolution computer screen and measured with a computerized caliper (Cardio Calipers, ver 3.3, ICONICO, NY, USA). Lead I, II, III, aVL, aVF, and Lead V1 were measured using Cardio Calipers, while PR intervals were automatically measured with the GE Marquette MAC 5000 (GE Marquette Inc., Milwaukee, WI). P wave durations in Lead I, II, III, aVL, and aVF were measured from the onset of the P wave to the return to the baseline. P wave amplitudes of the equivalent leads were measured from the crest of the P wave to the trough of the wave. The biphasic deflection in Lead V1 was measured as the following.
Duration of the initial positive deflection was measured from the onset of the P wave to the return to its baseline before the onset of the negative deflection.
Duration of negative P wave deflection was calculated by subtracting duration of the positive deflection from the duration of the entire P wave. Amplitude of the terminal negative deflection was measured from the trough of the wave to the baseline (Figure 1 ).
Figure 1.
Measurement of PR interval, P wave duration, and P wave amplitude in Lead V1. Representative images of a patient with rs2200733 CC genotype (A) and TT genotype (B) are shown.
Genotyping
We used whole blood sample for the DNA extraction and genetic analyses, and it was collected by using EDTA as an anticoagulant. Genotyping of 4q25 rs2200733, PITX2 rs6843082, ZFHX3 rs2106261, and KCNN3 rs13376333 was performed using the validated TaqMan assays (Life Technologies, Carlsbad, CA, USA). Polymerase chain reaction product was amplified using 0.9 µm each of the forward and reverse primers, 0. III. RESULTS
Clinical characteristics
All AF patients underwent RFCA, and 457 of them had paroxysmal (PAF) and 202 had persistent AF (PeAF). Baseline characteristics of AF patients and control are summarized in Table 1 . Abbreviations are the same as in Table 1 Figure 2.
Frequency of genotypes in Korean patients with AF vs. controls
Representative images of color-coded 3D voltage map of LA. LA voltage, especially venous LA voltage, is higher in a patient with rs2106261 AA genotype (A) than AG+GG (B).
Characteristics and predictors of clinical recurrence of AF after RFCA
The clinical recurrence after RFCA was observed in 26.2%. (Table 6 ). 
IV. DISCUSSION
In the present study, we found that both nuclear polymorphism at chromosome 4q25 PITX2 and 16q22 ZFHX3 detected from peripheral blood were associated with AF. The 4q25 rs2200733 and ZFHX3 rs2106261 genotypes were associated with electroanatomical remodeling of LA. The presence of variant allele of ZFHX3 rs2106261 was also associated with recurrence after RFCA.
AF is a hereditable disease and related to genetic polymorphisms
Although AF has been known to be a degenerative disease with a multifactorial background, such as aging and oxidative stress, growing evidence has shown that genetic variation may also play a role in the pathogenesis of AF. 30 Fox et al. 31 reported that a parental history of AF increased the risk of AF by 1.9 times, while Lubitz et al. 32 also showed a 39 % increase in the incidence of AF in patients with a family history of AF in their 1 st degree relatives. Recently, genome-wide associate studies revealed several nuclear polymorphisms significantly associated with AF, such as KCNN3 on chromosome 1q21, PITX2 on chromosome 4q25, and ZFHX3 on chromosome 16q22. 11, 33 Common SNPs in a non-coding region on chromosome 4q25 have been shown to be associated with AF, and rs2200733
is the most reliable genetic variant associated with AF. 7, 34 SNPs found in the 4q25 region are near PITX2, a gene believed to be involved in cardiac development, specifically sinus node development and susceptibility to atrial arrhythmias. 35 There is emerging evidence that highly conserved non-coding regions may act as regulatory elements and contribute to phenotypic diversity. 36 However, the mechanism by which genetic variation at the chromosome 4q25 locus leads to AF remains to be elucidated. In this study,
we evaluated the robust SNPs associated with AF, rs2200733 and rs6843082 at chromosome 4q25, rs2106261 at ZFHX3, and rs13376333 at KCNN3. The AF risk allele of SNP rs2200733 and that of SNP rs2106261 have been reported to be much more frequent among Chinese subjects, in both affected and unaffected individuals 11, 12 in concordance with our results. However, rs13376333 in KCNN3 was not associated with AF in our study population, which was not consistent with previous ones. 13 The possible explanation is that intrinsic racial differences in myocardial membrane stability, myocardial conduction pathways, or genetic polymorphisms cause different susceptibility to the development of AF. 37 Another possibility is that the difference could be a result of complicated gene-gene and gene-environment interactions, which can dilute or accentuate genetic effects in complex traits such as AF. Electrical isolation of those sleeves is a cornerstone for most AF ablation procedures. 27 PITX2c-deficient mice do not develop pulmonary myocardial sleeves. 10 Expression of PITX2 is remodeled during cardiac looping, becoming localized to the ventral portion of the developing ventricular chambers, while maintaining a distinct left-sided atrial expression. 40 In addition, PITX2 might also trigger AF by altering the conduction properties of the cardiac conduction system. Wang et al. 41 have demonstrated that PITX2
haplo insufficiency predisposes to AF in electrically stimulated adult mice.
Notably, ANK2, a gene for familial long QT syndrome, sinus node dysfunction, and AF, is also located near rs2200733. 42 The ZFHX3 gene on chromosome 16q22 encodes a transcription factor that was originally identified as a regulator of alpha-fetoprotein expression. 43 ZFHX3 has been associated with Kawasaki disease, as well as malignancies such as prostate cancer. However, in human cardiac and pulmonary tissue, its expression pattern and mechanism are not fully known. 44 The KCNN channels are also expressed in vascular endothelial cells, and suppression of KCNN3 expression in a mouse model has been associated with increased blood pressure. 45 In a rabbit burst-pacing model designed to simulate pulmonary venous ectopy, pharmacologic blockade of KCNN channels inhibited pacing-induced shortening of pulmonary venous and atrial action potential duration. 46 Shortening of the atrial action potential duration reduces the refractory period of atrial myocytes and promotes re-entry, an important mechanism for the development and maintenance of AF. 47 Although the association of rs13376333 in KCNN3 with AF was not demonstrated in the present study, a future research will be warranted to further investigate the association between them and elucidate the functional pathways behind. Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the heart rhythm society (hrs) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the european heart rhythm association (ehra), a registered branch of the european society of cardiology (esc) and the european cardiac arrhythmia society (ecas); and in collaboration with the american college of cardiology (acc), american heart association (aha), the asia pacific heart rhythm society (aphrs), and the society of thoracic surgeons (sts). Endorsed by the governing bodies of the american college of cardiology foundation, the american heart association, the european cardiac arrhythmia society, the european heart rhythm association, the society of thoracic surgeons, the asia pacific heart rhythm society, and the heart rhythm society. Heart Rhythm. 2012;9:632-696 e621 
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